8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC  20549

________________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) October 28, 2022

COLGATE-PALMOLIVE COMPANY

 (Exact name of registrant as specified in its charter)

Delaware	1-644	13-1815595
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

300 Park Avenue, New York, New York	10022
(Address of Principal Executive Offices)	(Zip Code)

Registrant’s telephone number, including area code (212) 310-2000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $1.00 par value	CL	New York Stock Exchange
0.500% Notes due 2026	CL 26	New York Stock Exchange
0.300% Notes due 2029	CL 29	New York Stock Exchange
1.375% Notes due 2034	CL 34	New York Stock Exchange
0.875% Notes due 2039	CL 39	New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition.

On October 28, 2022, Colgate-Palmolive Company (the “Company”) issued a press release announcing its earnings for the quarter ended September 30, 2022.  This press release is attached as Exhibit 99 and is incorporated herein by reference.

The information in Item 2.02 of this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section.  The information in Item 2.02 of this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.  The following exhibits are filed with this document:

Exhibit Number Description

99 Press release, dated October 28, 2022, issued by Colgate-Palmolive Company

104 Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)

2

EXHIBIT INDEX

Exhibit Number Description

99 Press release, dated October 28, 2022, issued by Colgate-Palmolive Company

104 Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)

3

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	COLGATE-PALMOLIVE COMPANY
Date:  October 28, 2022	By:     /s/ Stanley J. Sutula III
	Name: Stanley J. Sutula III
	Title:   Chief Financial Officer

4

EX-99

Exhibit 99

Colgate Announces 3rd Quarter 2022 Results

NEW YORK--(BUSINESS WIRE)--October 28, 2022--Colgate-Palmolive Company (NYSE:CL):

• Net sales increased 1.0%; Organic sales* increased 7.0% with growth in every division and all four categories
• GAAP EPS declined 1% to $0.74; Base Business EPS* declined 9% to $0.74, both of which reflect a negative foreign exchange translation impact of $0.05
• GAAP Gross profit margin and Base Business Gross profit margin* both decreased 220 basis points to 57.2%
• Net cash provided by operations was $1,883 million for the first nine months of 2022
• Colgate’s leadership in toothpaste continued with its global market share at 39.7% year to date
• Colgate’s leadership in manual toothbrushes continued with its global market share at 31.6% year to date
• The Company updated its financial guidance for full year 2022

Third Quarter Total Company Results (GAAP)
($ in millions except per share amounts)	2022	2021	Change
Net Sales	$4,455	$4,414	+1.0%
EPS (diluted)	$0.74	$0.75	-1%
Third Quarter Total Company Results (Base Business - Non-GAAP)*
($ in millions except per share amounts)	2022	2021	Change
Organic Sales Growth			+7.0%
Base Business EPS (diluted)	$0.74	$0.81	-9%

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 6 - Geographic Sales Analysis Percentage Changes” and “Table 8 - Non-GAAP Reconciliations” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

Colgate-Palmolive Company (NYSE:CL) today reported results for third quarter 2022. Noel Wallace, Chairman, President and Chief Executive Officer, commented on the Base Business third quarter results, “We are very pleased to have delivered our 15th consecutive quarter of organic sales growth at or above our targeted range of 3% to 5%. Net sales increased 1.0%, and organic sales grew 7.0% with growth in every division and in all four of our categories.

“The consistent, strong, broad-based growth is evidence that our strategies are working. Our focus on science-led, core and premium innovation is providing value at all price points, which is particularly important in today’s difficult macroeconomic environment. Our investments in building and scaling our digital and other capabilities across the enterprise are also paying off with our revenue growth management initiatives helping to drive double-digit pricing worldwide.

“As expected, significant increases in raw and packaging material and logistics costs continued during the quarter and the negative impact from currency accelerated. Beyond revenue growth management and the significant pricing actions we are taking, we are also continuing our efforts around funding-the-growth and other productivity initiatives to help offset these headwinds.

“Looking ahead, despite the challenging macroeconomic environment, we intend to continue to execute against our strategy in order to drive value for all stakeholders.”

Full Year 2022 Guidance

Based on current spot rates:

• The Company now expects net sales growth to be in the middle of the 1% to 4% range, including an approximately 5% negative impact from foreign exchange and a modest benefit from the Red Collar acquisition.
• The Company raised its organic sales growth guidance for the year from 5% to 7% to 6% to 7%.
• On a GAAP basis, the Company still expects a decline in gross profit margin and double-digit earnings-per-share growth, and now expects advertising investment to be roughly flat.
• On a non-GAAP (Base Business) basis, the Company still expects a decline in gross profit margin and now expects roughly flat advertising investment and a 7% to 8% earnings-per-share decline reflecting the incremental negative impact from foreign exchange due to the move in exchange rates since our second quarter earnings release.

Divisional Performance

The following are comments about divisional performance for third quarter 2022 versus the year ago period. See attached "Table 6 - Geographic Sales Analysis Percentage Changes" and "Table 5 - Segment Information" for additional information on net sales and operating profit by division.

Third Quarter Sales Growth By Division (% change 3Q 2022 vs. 3Q 2021)
	Net Sales	Organic Sales*	As Reported Volume	Organic Volume	Pricing	FX
North America	+3.0%	+3.5%	-5.5%	-5.5%	+9.0%	-0.5%
Latin America	+7.0%	+11.5%	-8.5%	-8.5%	+20.0%	-4.5%
Europe	-12.0%	+2.5%	-2.5%	-2.5%	+5.0%	-14.5%
Asia Pacific	-3.0%	+5.0%	-1.0%	-1.0%	+6.0%	-8.0%
Africa/Eurasia	+11.0%	+20.0%	-6.5%	-6.5%	+26.5%	-9.0%
Hill's	+3.0%	+7.5%	-3.5%	-3.5%	+11.0%	-4.5%
Total Company	+1.0%	+7.0%	-4.5%	-4.5%	+11.5%	-6.0%

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 6 - Geographic Sales Analysis Percentage Changes” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

Third Quarter Operating Profit By Division ($ in millions)
	3Q 2022	% Change vs 3Q 2021	% to Net Sales	Change in basis points vs 3Q 2021 % to Net Sales
North America	$198	8%	20.7%	+100
Latin America	$289	17%	29.0%	+240
Europe	$127	-29%	20.1%	-470
Asia Pacific	$185	-14%	26.1%	-330
Africa/Eurasia	$66	50%	23.0%	+590
Hill's	$201	-14%	23.1%	-450
Total Company, As Reported	$947	-2%	21.3%	-60
Total Company, Base Business*	$920	-5%	20.7%	-120

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 8 - Non-GAAP Reconciliations” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

North America (22% of Company Sales)

• Organic sales growth was broad based across oral care, personal care and home care.
• In the United States, Colgate's share of the toothpaste market is 34.6% year to date and its share of the manual toothbrush market is 42.3% year to date.
• The increase in Operating profit as a percentage of Net sales was primarily due to higher pricing, cost savings from the Company’s funding-the-growth initiatives and lower overhead expenses, partially offset by significantly higher raw and packaging material costs.

Latin America (22% of Company Sales)

• Organic sales growth was led by Brazil, Mexico, Argentina and Colombia.
• The increase in Operating profit as a percentage of Net sales was primarily due to higher pricing, cost savings from the Company’s funding-the-growth initiatives, a value-added tax refund and lower overhead expenses, partially offset by significantly higher raw and packaging material costs.

Europe (14% of Company Sales)

• Organic sales growth was led by the United Kingdom, Poland and France, partially offset by organic sales declines in the Filorga business.
• The decrease in Operating profit as a percentage of Net sales was primarily due to significantly higher raw and packaging material costs and higher logistics costs, partially offset by cost savings from the Company’s funding-the-growth initiatives, higher pricing, overhead efficiencies and decreased advertising investment.

Asia Pacific (16% of Company Sales)

• Organic sales growth was led by the Greater China region, Australia and the Philippines.
• The decrease in Operating profit as a percentage of Net sales was primarily due to significantly higher raw and packaging material costs and increased advertising investment, partially offset by cost savings from the Company's funding-the-growth initiatives and higher pricing.

Africa/Eurasia (6% of Company Sales)

• Organic sales growth was led by Turkiye and South Africa.
• The increase in Operating profit as a percentage of Net sales was primarily due to higher pricing, cost savings from the Company’s funding-the-growth initiatives, lower overhead expenses and decreased advertising investment, partially offset by significantly higher raw and packaging material costs.

Hill's Pet Nutrition (20% of Company Sales)

• Organic sales growth was led by the United States and Europe.
• The decrease in Operating profit as a percentage of Net sales was primarily due to significantly higher raw and packaging material costs and higher logistics costs, partially offset by higher pricing, decreased advertising investment, cost savings from the Company’s funding-the-growth initiatives and overhead efficiencies.

Prepared Materials and Webcast Information

At approximately 7:00 a.m. ET today, Colgate will post its prepared materials (in PDF format) regarding third quarter results to the Investor Center section of its website at https://investor.colgatepalmolive.com/events-and-presentations.

At 8:30 a.m. ET today, Colgate will host a conference call regarding third quarter results. To access this call as a webcast, please go to Colgate’s website at www.colgatepalmolive.com.

About Colgate-Palmolive

Colgate-Palmolive Company is a caring, innovative growth company reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our products in more than 200 countries and territories under brands such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom’s of Maine, EltaMD, Filorga, Irish Spring, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Soupline and Suavitel, as well as Hill’s Science Diet and Hill’s Prescription Diet. We are recognized for our leadership and innovation in promoting sustainability and community wellbeing, including our achievements in decreasing plastic waste and promoting recyclability, saving water, conserving natural resources and improving children’s oral health through the Colgate Bright Smiles, Bright Futures program, which has reached more than 1.4 billion children since 1991. For more information about Colgate’s global business and how we are building a future to smile about, visit www.colgatepalmolive.com. CL-E

Market Share Information

Management uses market share information as a key indicator to monitor business health and performance. References to market share in this press release are based on a combination of consumption and market share data provided by third-party vendors, primarily Nielsen, and internal estimates. All market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data (excluding Venezuela from all periods).

Market share data is subject to limitations on the availability of up-to-date information. In particular, market share data is currently not generally available for certain retail channels, such as eCommerce and certain club retailers and discounters. The Company measures year-to-date market shares from January 1 of the relevant year through the most recent period for which market share data is available, which typically reflects a lag time of one or two months. The Company believes that the third-party vendors it uses to provide data are reliable, but it has not verified the accuracy or completeness of the data or any assumptions underlying the data. In addition, market share information reported by the Company may be different from market share information reported by other companies due to differences in category definitions, the use of data from different countries, internal estimates and other factors.

Cautionary Statement on Forward-Looking Statements

This press release and the related webcast may contain forward-looking statements (as that term is defined in the U.S. Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission (SEC) in its rules, regulations and releases) that set forth anticipated results based on management’s current plans and assumptions. Such statements may relate, for example, to sales or volume growth, net selling price increases, organic sales growth, profit or profit margin levels, earnings per share levels, financial goals, the impact of foreign exchange, the impact of COVID-19, the impact of the war in Ukraine, cost-reduction plans, including the 2022 Global Productivity Initiative, tax rates, interest rates, new product introductions and digital capabilities, commercial investment levels, acquisitions, divestitures, share repurchases, or legal or tax proceedings, among other matters. These statements are made on the basis of the Company’s views and assumptions as of this time and the Company undertakes no obligation to update these statements whether as a result of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC. Moreover, the Company does not, nor does any other person, assume responsibility for the accuracy and completeness of these statements. The Company cautions investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements. For more information about factors that could impact the Company’s business and cause actual results to differ materially from forward-looking statements, investors should refer to the Company’s filings with the SEC (including, but not limited to, the information set forth under the captions “Risk Factors” and “Cautionary Statement on Forward-Looking Statements” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 and subsequent Quarterly Reports on Form 10-Q). Copies of these filings may be obtained upon request from the Company’s Investor Relations Department or on the Company’s website at www.colgatepalmolive.com.

Non-GAAP Financial Measures

The following provides definitions and other information regarding the non-GAAP financial measures used in this press release and the related prepared materials and webcast, which may not be the same as or comparable to similar measures presented by other companies:

• Base Business: Base Business refers to non-GAAP measures of operating results that exclude certain items. Base Business operating results exclude, as applicable, charges relating to the 2022 Global Productivity Initiative, a gain on the sale of land in Asia Pacific, acquisition-related costs, a loss on the early extinguishment of debt and a benefit related to a value-added tax matter in Brazil.

• Organic sales growth: Net sales growth excluding the impact of foreign exchange, acquisitions and divestments.

• Free cash flow before dividends: Net cash provided by operations less Capital expenditures.

This press release discusses Net sales growth (GAAP) and Organic sales growth (non-GAAP). Management believes the organic sales growth measure provides investors and analysts with useful supplemental information regarding the Company’s underlying sales trends by presenting sales growth excluding the external factor of foreign exchange as well as the impact from acquisitions and divestments. See “Geographic Sales Analysis Percentage Changes” for the three and nine months ended September 30, 2022 versus 2021 included with this release for a comparison of Organic sales growth to Net sales growth in accordance with GAAP.

Selling, general and administrative expenses, Selling, general and administrative expenses as a percentage of Net sales, Other (income) expense, net, Operating profit, Operating profit margin, Non-service related postretirement costs, Effective income tax rate, Net income attributable to Colgate-Palmolive Company and Diluted earnings per common share are disclosed on both an as reported (GAAP) and Base Business (non-GAAP) basis. These non-GAAP financial measures exclude items that, either by their nature or amount, management would not expect to occur as part of the Company’s normal business on a regular basis, such as restructuring charges, charges for certain litigation and tax matters, gains and losses from certain acquisitions, divestitures and certain other unusual, non-recurring items. Investors and analysts use these financial measures in assessing the Company’s business performance, and management believes that presenting these financial measures on a non-GAAP basis provides them with useful supplemental information to enhance their understanding of the Company’s underlying business performance and trends. These non-GAAP financial measures also enhance the ability to compare period-to-period financial results. See “Non-GAAP Reconciliations” for the three and nine months ended September 30, 2022 and 2021 included with this release for a reconciliation of these financial measures to the related GAAP measures.

The Company uses these financial measures internally in its budgeting process, to evaluate segment and overall operating performance and as factors in determining compensation. While the Company believes that these financial measures are useful in evaluating the Company’s underlying business performance and trends, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP.

As management uses free cash flow before dividends to evaluate the Company’s ability to satisfy current and future obligations, pay dividends, fund future business opportunities and repurchase stock, the Company believes that it provides useful information to investors. Free cash flow before dividends is not a measure of cash available for discretionary expenditures since the Company has certain non-discretionary obligations such as debt service that are not deducted from the measure. See “Condensed Consolidated Statements of Cash Flows” for the nine months ended September 30, 2022 and 2021 for a comparison of free cash flow before dividends to Net cash provided by operations as reported in accordance with GAAP.

(See attached tables for third quarter results.)

				Table 1
Colgate-Palmolive Company
Condensed Consolidated Statements of Income
For the Three Months Ended September 30, 2022 and 2021
(Dollars in Millions Except Per Share Amounts) (Unaudited)
		2022			2021
Net sales	$	4,455		$	4,414
Cost of sales		1,907			1,791
Gross profit		2,548			2,623
Gross profit margin		57.2	%		59.4	%
Selling, general and administrative expenses		1,634			1,636
Other (income) expense, net		(33	)		20
Operating profit		947			967
Operating profit margin		21.3	%		21.9	%
Non-service related postretirement costs		15			16
Interest (income) expense, net		40			98
Income before income taxes		892			853
Provision for income taxes		210			172
Effective tax rate		23.5	%		20.2	%
Net income including noncontrolling interests		682			681
Less: Net income attributable to noncontrolling interests		64			47
Net income attributable to Colgate-Palmolive Company	$	618		$	634
Earnings per common share
Basic	$	0.74		$	0.75
Diluted	$	0.74		$	0.75
Supplemental Income Statement Information
Average common shares outstanding
Basic		835.7			843.6
Diluted		838.5			846.4
Advertising	$	486		$	503

				Table 2
Colgate-Palmolive Company
Condensed Consolidated Statements of Income
For the Nine Months Ended September 30, 2022 and 2021
(Dollars in Millions Except Per Share Amounts) (Unaudited)
		2022			2021
Net sales	$	13,338		$	13,018
Cost of sales		5,664			5,202
Gross profit		7,674			7,816
Gross profit margin		57.5	%		60.0	%
Selling, general and administrative expenses		4,932			4,809
Other (income) expense, net		51			40
Operating profit		2,691			2,967
Operating profit margin		20.2	%		22.8	%
Non-service related postretirement costs		65			52
Interest (income) expense, net		98			152
Income before income taxes		2,528			2,763
Provision for income taxes		604			613
Effective tax rate		23.9	%		22.2	%
Net income including noncontrolling interests		1,924			2,150
Less: Net income attributable to noncontrolling interests		144			132
Net income attributable to Colgate-Palmolive Company	$	1,780		$	2,018
Earnings per common share
Basic(1)	$	2.12		$	2.39
Diluted(1)	$	2.12		$	2.38
Supplemental Income Statement Information
Average common shares outstanding
Basic		837.7			845.9
Diluted		840.4			849.0
Advertising	$	1,493		$	1,532

Note:

(1) Basic and diluted earnings per share are computed independently for each quarter and any year-to-date period presented. As a result of changes in shares outstanding during the year and rounding, the sum of the quarters' earnings per share may not equal the earnings per share for any year-to-date period.

							Table 3
Colgate-Palmolive Company
Condensed Consolidated Balance Sheets
As of September 30, 2022, December 31, 2021 and September 30, 2021
(Dollars in Millions) (Unaudited)
	September 30,			December 31,			September 30,
		2022			2021			2021
Cash and cash equivalents	$	938		$	832		$	958
Receivables, net		1,425			1,297			1,424
Inventories		2,073			1,692			1,670
Other current assets		842			576			618
Property, plant and equipment, net		4,123			3,730			3,633
Goodwill		3,538			3,284			3,685
Other intangible assets, net		2,219			2,462			2,719
Other assets		1,130			1,167			1,173
Total assets	$	16,288		$	15,040		$	15,880
Total debt	$	8,248		$	7,245		$	7,696
Other current liabilities		4,463			4,000			4,267
Other non-current liabilities		2,524			2,824			2,890
Total liabilities		15,235			14,069			14,853
Total Colgate-Palmolive Company shareholders’ equity		622			609			591
Noncontrolling interests		431			362			436
Total liabilities and equity	$	16,288		$	15,040		$	15,880
Supplemental Balance Sheet Information
Debt less cash, cash equivalents and marketable securities(1)	$	7,102		$	6,379		$	6,638
Working capital % of sales		(1.9	)%		(2.7	)%		(3.8	)%

Note:

(1) Marketable securities of $208, $34 and $100 as of September 30, 2022, December 31, 2021 and September 30, 2021, respectively, are included in Other current assets.

				Table 4
Colgate-Palmolive Company
Condensed Consolidated Statements of Cash Flows
For the Nine Months Ended September 30, 2022 and 2021
(Dollars in Millions) (Unaudited)
		2022			2021
Operating Activities
Net income including noncontrolling interests	$	1,924		$	2,150
Adjustments to reconcile Net income including noncontrolling interests to Net cash provided by operations:
Depreciation and amortization		410			414
Restructuring and termination benefits, net of cash		51			(19	)
Stock-based compensation expense		105			107
Gain on sale of land		(47	)		—
Forward starting swap settlement		82			—
Loss on early extinguishment of debt		—			75
Deferred income taxes		(13	)		(146	)
Cash effects of changes in:
Receivables		(171	)		(198	)
Inventories		(422	)		(37	)
Accounts payable and other accruals		9			(107	)
Other non-current assets and liabilities		(45	)		(20	)
Net cash provided by (used in) operations		1,883			2,219
Investing Activities
Capital expenditures		(475	)		(374	)
Purchases of marketable securities and investments		(239	)		(118	)
Proceeds from sale of marketable securities and investments		55			55
Payment for acquisition, net of cash acquired		(817	)		—
Proceeds from sale of land		47			—
Other investing activities		1			(25	)
Net cash provided by (used in) investing activities		(1,428	)		(462	)
Financing Activities
Short-term borrowing (repayment) less than 90 days, net		(56	)		205
Principal payments on debt		(2	)		(118	)
Proceeds from issuance of debt		1,513			119
Dividends paid		(1,206	)		(1,183	)
Purchases of treasury shares		(895	)		(964	)
Proceeds from exercise of stock options		398			282
Other		(38	)		(9	)
Net cash provided by (used in) financing activities		(286	)		(1,668	)
Effect of exchange rate changes on Cash and cash equivalents		(63	)		(19	)
Net increase (decrease) in Cash and cash equivalents		106			70
Cash and cash equivalents at beginning of the period		832			888
Cash and cash equivalents at end of the period	$	938		$	958
Supplemental Cash Flow Information
Free cash flow before dividends (Net cash provided by operations less Capital expenditures)
Net cash provided by operations	$	1,883		$	2,219
Less: Capital expenditures		(475	)		(374	)
Free cash flow before dividends	$	1,408		$	1,845
Income taxes paid	$	690		$	742

										Table 5
Colgate-Palmolive Company
Segment Information
For the Three and Nine Months Ended September 30, 2022 and 2021
(Dollars in Millions) (Unaudited)
	Three Months Ended September 30,						Nine Months Ended September 30,
		2022			2021			2022			2021
Net Sales
Oral, Personal and Home Care
North America	$	958		$	931		$	2,850		$	2,765
Latin America		997			931			2,970			2,745
Europe		632			718			1,925			2,144
Asia Pacific		709			731			2,131			2,142
Africa/Eurasia		287			258			809			796
Total Oral, Personal and Home Care		3,583			3,569			10,685			10,592
Pet Nutrition		872			845			2,653			2,426
Total Net Sales	$	4,455		$	4,414		$	13,338		$	13,018
	Three Months Ended September 30,						Nine Months Ended September 30,
		2022			2021			2022			2021
Operating Profit
Oral, Personal and Home Care
North America	$	198		$	183		$	557		$	585
Latin America		289			248			818			774
Europe		127			178			410			524
Asia Pacific		185			215			556			639
Africa/Eurasia		66			44			160			153
Total Oral, Personal and Home Care		865			868			2,501			2,675
Pet Nutrition		201			233			617			661
Corporate(1)		(119	)		(134	)		(427	)		(369	)
Total Operating Profit	$	947		$	967		$	2,691		$	2,967

Note:

(1) Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets.

Corporate Operating profit (loss) for the three months ended September 30, 2022 included charges resulting from the 2022 Global Productivity Initiative of $3, a gain on the sale of land in Asia Pacific of $47 and acquisition-related costs of $17.

Corporate Operating profit (loss) for the nine months ended September 30, 2022 included charges resulting from the 2022 Global Productivity Initiative of $79, a gain on the sale of land in Asia Pacific of $47 and acquisition-related costs of $17.

Corporate Operating profit (loss) for the nine months ended September 30, 2021 included a benefit related to a value-added tax matter in Brazil of $26.

Table 6
Colgate-Palmolive Company
Geographic Sales Analysis Percentage Changes
For the Three Months Ended September 30, 2022 vs. 2021
(Unaudited)
					COMPONENTS OF SALES CHANGE
									Pricing
									Coupons
	Sales								Consumer &
	Change		Organic		As Reported		Organic		Trade		Foreign
Region	As Reported		Sales Change		Volume		Volume		Incentives		Exchange
Total Company	1.0	%	7.0	%	(4.5	)%	(4.5	)%	11.5	%	(6.0	)%
North America	3.0	%	3.5	%	(5.5	)%	(5.5	)%	9.0	%	(0.5	)%
Latin America	7.0	%	11.5	%	(8.5	)%	(8.5	)%	20.0	%	(4.5	)%
Europe	(12.0	)%	2.5	%	(2.5	)%	(2.5	)%	5.0	%	(14.5	)%
Asia Pacific	(3.0	)%	5.0	%	(1.0	)%	(1.0	)%	6.0	%	(8.0	)%
Africa/Eurasia	11.0	%	20.0	%	(6.5	)%	(6.5	)%	26.5	%	(9.0	)%
Total CP Products	0.5	%	7.0	%	(5.0	)%	(5.0	)%	12.0	%	(6.5	)%
Hill’s	3.0	%	7.5	%	(3.5	)%	(3.5	)%	11.0	%	(4.5	)%
Emerging Markets(1)	3.0	%	9.5	%	(6.5	)%	(6.5	)%	16.0	%	(6.5	)%
Developed Markets	(0.5	)%	5.0	%	(3.0	)%	(3.0	)%	8.0	%	(5.5	)%

Note:

(1) Emerging Markets include Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe.

Table 7
Colgate-Palmolive Company
Geographic Sales Analysis Percentage Changes
For the Nine Months Ended September 30, 2022 vs. 2021
(Unaudited)
					COMPONENTS OF SALES CHANGE
									Pricing
									Coupons
	Sales								Consumer &
	Change		Organic		As Reported		Organic		Trade		Foreign
Region	As Reported		Sales Change		Volume		Volume		Incentives		Exchange
Total Company	2.5	%	6.5	%	(2.0	)%	(2.0	)%	8.5	%	(4.0	)%
North America	3.0	%	3.5	%	(0.5	)%	(0.5	)%	4.0	%	(0.5	)%
Latin America	8.0	%	10.0	%	(4.0	)%	(4.0	)%	14.0	%	(2.0	)%
Europe	(10.5	)%	—	%	(3.5	)%	(3.5	)%	3.5	%	(10.5	)%
Asia Pacific	(0.5	)%	5.0	%	(0.5	)%	(0.5	)%	5.5	%	(5.5	)%
Africa/Eurasia	1.5	%	10.5	%	(10.0	)%	(10.0	)%	20.5	%	(9.0	)%
Total CP Products	1.0	%	5.0	%	(2.5	)%	(2.5	)%	7.5	%	(4.0	)%
Hill’s	9.5	%	13.0	%	2.0	%	2.0	%	11.0	%	(3.5	)%
Emerging Markets(1)	3.5	%	7.5	%	(4.0	)%	(4.0	)%	11.5	%	(4.0	)%
Developed Markets	1.5	%	5.5	%	—	%	—	%	5.5	%	(4.0	)%

Note:

(1) Emerging Markets include Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe.

Table 8
Colgate-Palmolive Company
Non-GAAP Reconciliations
For the Three Months Ended September 30, 2022 and 2021
(Dollars in Millions Except Per Share Amounts) (Unaudited)
Selling, General and Administrative Expenses		2022			2021
Selling, general and administrative expenses, GAAP	$	1,634		$	1,636
2022 Global Productivity Initiative		(1	)		—
Selling, general and administrative expenses, non-GAAP	$	1,633		$	1,636
Other (Income) Expense, Net		2022			2021
Other (income) expense, net, GAAP	$	(33	)	$	20
2022 Global Productivity Initiative		(2	)		—
Gain on the sale of land in Asia Pacific		47			—
Acquisition-related costs		(17	)		—
Other (income) expense, net, non-GAAP	$	(5	)	$	20
Operating Profit		2022			2021		% Change
Operating profit, GAAP	$	947		$	967			(2	)%
2022 Global Productivity Initiative		3			—
Gain on the sale of land in Asia Pacific		(47	)		—
Acquisition-related costs		17			—
Operating profit, non-GAAP	$	920		$	967			(5	)%
							Basis Point
Operating Profit Margin		2022			2021		Change
Operating profit margin, GAAP		21.3	%		21.9	%		(60	)
2022 Global Productivity Initiative		0.1	%		—	%
Gain on the sale of land in Asia Pacific		(1.1	)%		—	%
Acquisition-related costs		0.4	%		—	%
Operating profit margin, non-GAAP		20.7	%		21.9	%		(120	)
Interest (Income) Expense, Net		2022			2021
Interest (income) expense, net, GAAP	$	40		$	98
Loss on early extinguishment of debt		—			(75	)
Interest (income) expense, net, non-GAAP	$	40		$	23
Non-Service Related Postretirement Costs		2022			2021
Non-service related postretirement costs, GAAP	$	15		$	16
2022 Global Productivity Initiative		1			—
Non-service related postretirement costs, non-GAAP	$	16		$	16

Table 8
Continued
Colgate-Palmolive Company
Non-GAAP Reconciliations
For the Three Months Ended September 30, 2022 and 2021
(Dollars in Millions Except Per Share Amounts) (Unaudited)
	2022
	Income Before Income Taxes			Provision For Income Taxes(1)			Net Income Including Noncontrolling Interests			Less: Income Attributable to Noncontrolling Interests			Net Income Attributable To Colgate- Palmolive Company			Effective Income Tax Rate(2)			Diluted Earnings Per Share
As Reported GAAP	$	892		$	210		$	682		$	64		$	618			23.5	%	$	0.74
2022 Global Productivity Initiative		2			—			2			—			2			(0.1	)%		—
Gain on the sale of land in Asia Pacific		(47	)		(11	)		(36	)		(21	)		(15	)		0.1	%		(0.02	)
Acquisition-related costs		17			2			15			—			15			(0.2	)%		0.02
Non-GAAP	$	864		$	201		$	663		$	43		$	620			23.3	%	$	0.74
	2021
	Income Before IncomeTaxes			Provision For Income Taxes(1)			Net Income Including Noncontrolling Interests			Less: Income Attributable to Noncontrolling Interests			Net Income Attributable To Colgate- Palmolive Company			Effective Income Tax Rate(2)			Diluted Earnings Per Share
As Reported GAAP	$	853		$	172		$	681		$	47		$	634			20.2	%	$	0.75
Loss on early extinguishment of debt		75			20			55			—			55			0.5	%		0.06
Non-GAAP	$	928		$	192		$	736		$	47		$	689			20.7	%	$	0.81

The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.

Notes:

(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

(2) The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes.

Table 9
Colgate-Palmolive Company
Non-GAAP Reconciliations
For the Nine Months Ended September 30, 2022 and 2021
(Dollars in Millions Except Per Share Amounts) (Unaudited)
Selling, General and Administrative Expenses		2022			2021
Selling, general and administrative expenses, GAAP	$	4,932		$	4,809
2022 Global Productivity Initiative		(4	)		—
Selling, general and administrative expenses, non-GAAP	$	4,928		$	4,809
							Basis Point
Selling, General and Administrative Expenses as a Percentage of Net Sales		2022			2021		Change
Selling, general and administrative expenses as a percentage of Net sales, GAAP		37.0	%		36.9	%		10
2022 Global Productivity Initiative		(0.1	)%		—	%
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP		36.9	%		36.9	%		—
Other (Income) Expense, Net		2022			2021
Other (income) expense, net, GAAP	$	51		$	40
2022 Global Productivity Initiative		(75	)		—
Gain on the sale of land in Asia Pacific		47			—
Acquisition-related costs		(17	)		—
Value-added tax matter in Brazil		—			26
Other (income) expense, net, non-GAAP	$	6		$	66
Operating Profit		2022			2021		% Change
Operating profit, GAAP	$	2,691		$	2,967			(9	)%
2022 Global Productivity Initiative		79			—
Gain on the sale of land in Asia Pacific		(47	)		—
Acquisition-related costs		17			—
Value-added tax matter in Brazil		—			(26	)
Operating profit, non-GAAP	$	2,740		$	2,941			(7	)%
							Basis Point
Operating Profit Margin		2022			2021		Change
Operating profit margin, GAAP		20.2	%		22.8	%		(260	)
2022 Global Productivity Initiative		0.6	%		—	%
Gain on the sale of land in Asia Pacific		(0.4	)%		—	%
Acquisition-related costs		0.1	%		—	%
Value-added tax matter in Brazil		—	%		(0.2	)%
Operating profit margin, non-GAAP		20.5	%		22.6	%		(210	)
Interest (Income) Expense, Net		2022			2021
Interest (income) expense, net, GAAP	$	98		$	152
Loss on early extinguishment of debt		—			(75	)
Interest (income) expense, net, non-GAAP	$	98		$	77
Non-Service Related Postretirement Costs		2022			2021
Non-service related postretirement costs, GAAP	$	65		$	52
2022 Global Productivity Initiative		(13	)		—
Non-service related postretirement costs, non-GAAP	$	52		$	52

Table 9
Continued
Colgate-Palmolive Company
Non-GAAP Reconciliations
For the Nine Months Ended September 30, 2022 and 2021
(Dollars in Millions Except Per Share Amounts) (Unaudited)
	2022
	Income Before Income Taxes			Provision For Income Taxes(1)			Net Income Including Noncontrolling Interests			Less: Income Attributable to Noncontrolling Interests			Net Income Attributable To Colgate-Palmolive Company			Effective Income Tax Rate(2)			Diluted Earnings Per Share
As Reported GAAP	$	2,528		$	604		$	1,924		$	144		$	1,780			23.9	%	$	2.12
2022 Global Productivity Initiative		92			19			73			1			72			(0.1	)%		0.08
Gain on the sale of land in Asia Pacific		(47	)		(11	)		(36	)		(21	)		(15	)		—	%		(0.02	)
Acquisition-related costs		17			2			15			—			15			(0.1	)%		0.02
Non-GAAP	$	2,590		$	614		$	1,976		$	124		$	1,852			23.7	%	$	2.20
	2021
	Income Before Income Taxes			Provision For Income Taxes(1)			Net Income Including Noncontrolling Interests			Less: Income Attributable to Noncontrolling Interests			Net Income Attributable To Colgate-Palmolive Company			Effective Income Tax Rate(2)			Diluted Earnings Per Share
As Reported GAAP	$	2,763		$	613		$	2,150		$	132		$	2,018			22.2	%	$	2.38
Loss on early extinguishment of debt		75			20			55			—			55			0.1	%		0.06
Value-added tax matter in Brazil		(26	)		(6	)		(20	)		—			(20	)		—	%		(0.02	)
Non-GAAP	$	2,812		$	627		$	2,185		$	132		$	2,053			22.3	%	$	2.42

The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.

Notes:

(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

(2) The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustments on Income before income taxes and Provision for income taxes.

Contacts

John Faucher 212-310-3653
Hope Spiller 212-310-2291

XML

Document and Entity Information	Oct. 28, 2022
Entity Listings [Line Items]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Oct. 28, 2022
Entity Registrant Name	COLGATE-PALMOLIVE COMPANY
Entity Incorporation, State or Country Code	DE
Entity File Number	1-644
Entity Tax Identification Number	13-1815595
Entity Address, Address Line One	300 Park Avenue
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10022
City Area Code	212
Local Phone Number	310-2000
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Entity Emerging Growth Company	false
Entity Central Index Key	0000021665
1.375% Notes due 2034 [Member]
Entity Listings [Line Items]
Title of 12(b) Security	1.375% Notes due 2034
Trading Symbol	CL 34
Security Exchange Name	NYSE
0.500% Notes due 2026 [Member]
Entity Listings [Line Items]
Title of 12(b) Security	0.500% Notes due 2026
Trading Symbol	CL 26
Security Exchange Name	NYSE
Common Stock, $1.00 par value [Member]
Entity Listings [Line Items]
Title of 12(b) Security	Common Stock, $1.00 par value
Trading Symbol	CL
Security Exchange Name	NYSE
0.875% Notes due 2039 [Member]
Entity Listings [Line Items]
Title of 12(b) Security	0.875% Notes due 2039
Trading Symbol	CL 39
Security Exchange Name	NYSE
0.300% Notes due 2029 [Member]
Entity Listings [Line Items]
Title of 12(b) Security	0.300% Notes due 2029
Trading Symbol	CL 29
Security Exchange Name	NYSE